In the past few years, the market for Point of Care Testing (POCT) has grown by leaps and bounds. The need of more accurate and easily available diagnostic tests. Also, the global population above the age of 65 has grown by large numbers. The reason is the increase in life expectancy due to the great technological advances made in the Healthcare industry. On the other hand, an increase in chronic diseases has also been witnessed. All this has led to an increase in the demand of In-Vitro Diagnostics (IVD). These are tests that are much more precise and more importantly belong to the minimally invasive category. These tests are performed on the blood samples or tissues of the patient. The various examples of IVDs are blood sugar tests, pregnancy tests and now, various genetic tests are also available. Such IVDs, which can be performed at the site of patient or near it are called Point of Care Testing. Not only patients but even hospitals have increased the use of POCT in emergency